News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Apr 11, 2025, 15:47

Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients

Muzaffar Qazilbash, Professor of Medicine at UT- MD Anderson Cancer Center, shared a post on X:

“Major microbiome disruption was associated with toxicities following ide-cel administration in patients with multiple myeloma.”

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Authors: Satabdi Saha et al.

Idecabtagene Vicleucel

Abdur Rehman cancer Chia-Chi Chang Christine Peterson Christopher R. Flowers Donna M Weber Doris K. Hansen Elizabeth J. Shpall Faezeh Darbaniyan Frederick L. Locke Hans C. Lee idecabtagene vicleucel Krina K. Patel Lubna Rehman Mahmoud R Gaballa Marco L. Davila Mark R. Tanner Meghan Menges Melody Becnel Michael D. Jain Muzaffar Qazilbash Neeraj Y Saini OncoDaily Oncology Reetakshi Arora Robert R Jenq Robert Z. Orlowski Salvatore Corallo Satabdi Saha Sattva S. Neelapu Sheeba K. Thomas
Special Coverage
Oncolibrary
Jul 11, 2025, 00:41
Hormonal Replacement Therapy in Cancer Survivors: Safety, Benefits, and Clinical Guidelines
Blog
Jul 10, 2025, 21:33
Today Marks the Beginning of Module 1 of the 2nd SIOP Europe Course in Paediatric Oncology
Blog
Jul 10, 2025, 21:24
At AACR25, Douglas Hanahan Showed That IL-1 Family Signaling Drives Systemic Immunosuppression in HPV Cancers
Blog
Jul 10, 2025, 21:13
Raelyn Was Just 4 Years Old When She Was Diagnosed With T-Cell Acute Lymphoblastic Leukemia - St. Baldrick's Foundation
Blog
Jul 10, 2025, 20:58
Janna Sisakyan: I Am Excited to Carry These Lessons Forward in My Future Medical Career
Blog
Jul 10, 2025, 20:44
We’re Excited to Announce That the First Patient Has Been Randomised in the PROLoNG Study - EORTC
Blog
Jul 10, 2025, 20:32
Paolo Tarantino: Incredibly Excited to Co-Chair the NRG Oncology Summer Symposium 2025
Blog
Jul 10, 2025, 20:21
Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas
Insight
Jul 10, 2025, 20:08
Pashtoon Kasi: The 1st Agnostic Study of a PARP Inhibitor
Drugs
Jul 10, 2025, 16:59
Taletrectinib (Ibtrozi): What Patients Should Know About in 2025?
Blog
Jul 10, 2025, 16:30
Indiana’s First Mobile Lung Screening Unit Proves That Access to Care Saves Lives - IU Simon Comprehensive Cancer Center
Blog
Jul 10, 2025, 16:24
Herbert Loong: Had an Opportunity to Introduce and Discuss Soft Tissue Sarcomas at Radio Television Hong Kong